Self-monitoring Blood Glucose Devices Market

Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.

Self-monitoring Blood Glucose Devices Market contains market size and forecasts of Self-monitoring Blood Glucose Devices in global, including the following market information:

• Global Self-monitoring Blood Glucose Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Self-monitoring Blood Glucose Devices Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Self-monitoring Blood Glucose Devices companies in 2021 (%)

The global Self-monitoring Blood Glucose Devices market was valued at 9161.2 million in 2021 and is projected to reach US$ 11460 million by 2028, at a CAGR of 3.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Strips Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Self-monitoring Blood Glucose Devices include Roche Roche Diagnostics, Lifescan, Abbott Laboratories, Terumo and Ascensia(Bayer), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Self-monitoring Blood Glucose Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Self-monitoring Blood Glucose Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Self-monitoring Blood Glucose Devices Market Segment Percentages, by Type, 2021 (%)

• Strips
• Glucose Meter
• Lancet
• Other

Global Self-monitoring Blood Glucose Devices Market, by SaleChannel, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Self-monitoring Blood Glucose Devices Market Segment Percentages, by SaleChannel, 2021 (%)

• Public Hospital
• Private Hospital
• Clinics
• Pharmacy Shops

Global Self-monitoring Blood Glucose Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Self-monitoring Blood Glucose Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Self-monitoring Blood Glucose Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Self-monitoring Blood Glucose Devices revenues share in global market, 2021 (%)
• Key companies Self-monitoring Blood Glucose Devices sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Self-monitoring Blood Glucose Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche Roche Diagnostics
• Lifescan
• Abbott Laboratories
• Terumo
• Ascensia(Bayer)